Clinical Trial Update: Study of ORL-1B in Patients With Biotinidase Deficiency [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ORL-1B in biotinidase deficiency across Phase 1 and Phase 2 (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biotinidase Deficiency

Drugs mentioned

• ORL-1B

Snippet

Sponsor: Orpha Labs | Conditions: Biotinidase Deficiency | Phase 1, Phase 2 | Status: COMPLETED